DE60319599D1 - Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle eine neurodegenerative krankheit - Google Patents

Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle eine neurodegenerative krankheit

Info

Publication number
DE60319599D1
DE60319599D1 DE60319599T DE60319599T DE60319599D1 DE 60319599 D1 DE60319599 D1 DE 60319599D1 DE 60319599 T DE60319599 T DE 60319599T DE 60319599 T DE60319599 T DE 60319599T DE 60319599 D1 DE60319599 D1 DE 60319599D1
Authority
DE
Germany
Prior art keywords
stem cell
differentiating
nervencell
nervencel
neurodeegenerative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60319599T
Other languages
English (en)
Other versions
DE60319599T2 (de
DE60319599T8 (de
Inventor
Hyun-Soo Kim
Young-Mo Kang
Kyung-Bock Lee
Sang-Kyo Park
Sang-Kap Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FCB-Pharmicell Co Ltd
Original Assignee
FCB-Pharmicell Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FCB-Pharmicell Co Ltd filed Critical FCB-Pharmicell Co Ltd
Application granted granted Critical
Publication of DE60319599D1 publication Critical patent/DE60319599D1/de
Publication of DE60319599T2 publication Critical patent/DE60319599T2/de
Publication of DE60319599T8 publication Critical patent/DE60319599T8/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
DE60319599T 2003-10-29 2003-10-29 Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle enthaltende pharmazeutische zusammensetzung gegen eine neurodegenerative krankheit Active DE60319599T8 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2003/002302 WO2005040362A1 (en) 2003-10-29 2003-10-29 Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease

Publications (3)

Publication Number Publication Date
DE60319599D1 true DE60319599D1 (de) 2008-04-17
DE60319599T2 DE60319599T2 (de) 2008-06-26
DE60319599T8 DE60319599T8 (de) 2008-10-16

Family

ID=34510740

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60319599T Active DE60319599T8 (de) 2003-10-29 2003-10-29 Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle enthaltende pharmazeutische zusammensetzung gegen eine neurodegenerative krankheit

Country Status (10)

Country Link
US (1) US7635591B2 (de)
EP (1) EP1687413B8 (de)
JP (1) JP4126060B2 (de)
CN (1) CN100554409C (de)
AT (1) ATE388223T1 (de)
AU (1) AU2003273118B2 (de)
CA (1) CA2543118C (de)
DE (1) DE60319599T8 (de)
HK (1) HK1093755A1 (de)
WO (1) WO2005040362A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807458B2 (en) 2003-01-30 2010-10-05 The United States Of America As Represented By The Secretary Of The Department Of Veterans Affairs Multilineage-inducible cells and uses thereof
ATE470199T1 (de) * 2003-04-24 2010-06-15 Koninkl Philips Electronics Nv Eingriffsfreie links-herzkammervolumenbestimmung
US20090136461A1 (en) * 2007-11-28 2009-05-28 Moon Suk Kim Neuronal differentiation method of adult stem cells using small molecules
US20120156134A1 (en) 2007-12-20 2012-06-21 Shayne Squires Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
CA2734236C (en) 2008-08-20 2020-08-25 Anthrogenesis Corporation Improved cell composition and methods of making the same
US8790638B2 (en) * 2009-02-04 2014-07-29 Stemedica Cell Technologies, Inc. Compositions of stem cells and stem cell factors and methods for their use and manufacture
CA2756670A1 (en) 2009-03-26 2010-09-30 The Regents Of The University Of California Mesenchymal stem cells producing inhibitory rna for disease modification
CN101948803B (zh) * 2010-09-13 2012-09-05 中山大学中山眼科中心 人表皮源性间充质干细胞样多能细胞及其制备方法
EP2709636A2 (de) * 2011-05-19 2014-03-26 Ariel-University Research and Development Company Ltd. Verwendung von mesenchymalen stammzellen zur verbesserung der affektiven und der kognitiven funktion
KR101446711B1 (ko) * 2011-05-23 2014-10-06 아주대학교산학협력단 간세포 성장인자 유전자 및 염기성 나선-고리-나선 계열의 신경형성 전사인자 유전자가 도입된 성체 줄기세포주 및 그의 용도
US20140065110A1 (en) 2012-08-31 2014-03-06 The Regents Of The University Of California Genetically modified msc and therapeutic methods
CN103275070A (zh) * 2013-05-10 2013-09-04 郑彪 调节单核细胞增殖的四环化合物及其应用
CN103919806A (zh) * 2014-04-09 2014-07-16 大连医科大学 骨髓间充质干细胞作为治疗正己烷致周围性神经病的药物的应用
CN104004713A (zh) * 2014-05-14 2014-08-27 安沂华 脐带间充质干细胞诱导培养为神经细胞的方法
CN106795490B (zh) * 2014-09-11 2021-01-19 台湾粒线体应用技术股份有限公司 用线粒体特化细胞治疗神经退行性疾病的医药组合物
WO2022046771A1 (en) * 2020-08-24 2022-03-03 The Johns Hopkins University Juvenile protective factors to arrest and reverse aging in the enteric nervous system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214334B1 (en) * 1991-10-21 2001-04-10 Trustees Of The University Of Pennsylvania Compositions and methods for producing and using homogenous neuronal cell transplants to treat neurodegenerative disorders and brain and spinal cord injuries
CN1170435A (zh) * 1994-11-14 1998-01-14 纽罗斯菲里斯控股有限公司 神经干细胞增殖的调节
US5736396A (en) * 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US7015037B1 (en) * 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
KR100449141B1 (ko) 2001-04-19 2004-09-21 (주)라이프코드 간엽 간세포를 신경세포로 분화시키는 방법
AU2003302707B2 (en) * 2002-12-02 2008-10-02 Anges Mg, Inc. Method for culturing neural stem cells using hepatocyte growth factor

Also Published As

Publication number Publication date
EP1687413A4 (de) 2006-11-08
CN1860224A (zh) 2006-11-08
DE60319599T2 (de) 2008-06-26
EP1687413B8 (de) 2008-10-01
AU2003273118B2 (en) 2007-05-17
ATE388223T1 (de) 2008-03-15
JP2007528196A (ja) 2007-10-11
EP1687413A1 (de) 2006-08-09
DE60319599T8 (de) 2008-10-16
JP4126060B2 (ja) 2008-07-30
EP1687413B1 (de) 2008-03-05
AU2003273118A1 (en) 2005-05-11
US20070054399A1 (en) 2007-03-08
CN100554409C (zh) 2009-10-28
CA2543118A1 (en) 2005-05-06
CA2543118C (en) 2009-10-06
WO2005040362A1 (en) 2005-05-06
HK1093755A1 (en) 2007-03-09
US7635591B2 (en) 2009-12-22

Similar Documents

Publication Publication Date Title
HK1093755A1 (en) Method for differentiating mesenchymal stem cell into neural cell
DE602004025805D1 (de) Verfahren zur herstellung von antikörpern
ATE474910T1 (de) L-glutaminsäure produzierender mikroorganismus sowie verfahren zur produktion von l- glutaminsäure
ATE468390T1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
DK1888742T3 (da) Leverstamceller
EA200601187A1 (ru) Стволовые клетки
WO2004081205A8 (en) Differentiation of human embryonic stem cells to cardiomyocytes
DK1155116T3 (da) Anvendelse af kollagenase i fremstillingen af kulturer af neurale stamceller
DK1759536T3 (da) In vitro-teknikker til anvendelse med stamceller
PL2447357T3 (pl) Sposoby wytwarzania mikromieszków włosowych i brodawek de novo i stosowanie ich w badaniach in vitro i przeszczepach in vivo
NZ569543A (en) Means and methods for influencing the stability of antibody producing cells
PT1415158E (pt) Metodo para seleccao de celulas que expressam anticorpos
DE602005020638D1 (de) Selektives kultivierungsverfahren und trennverfahren für kleine hepatozyten mit verwendung von hyaluronsäure
DE60323652D1 (de) Verfahren zur detektion und zählung von mikroorganismen in einer probe
DE602005019156D1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
WO2015121859A8 (en) Method of qualifying cells
GB2453074A (en) Differentiation of primate pluripotent cells to hepatocyte-lineage cells
MX2014001441A (es) Metodo para aumentar la asimilación de dioxido de carbono (co2) y la producción de aceite en organismos fotosinteticos.
CN104215616A (zh) 基于叶绿素荧光的浮游植物光合速率快速检测方法
MX2012007117A (es) Metodo para cultivar celulas adherentes.
SG11201806843UA (en) Method for producing activated hepatocyte growth factor (hgf)
ATE462013T1 (de) Verfahren zur kultivierung von zellen zur produktion von substanzen
WO2006119860A8 (de) Zellkultursystem sowie verfahren zur kultivierung einer zellkultur
EP1650301B8 (de) Gene, die pflanzenregenerierung ermöglichen, und deren verwendungen
FR2948381B1 (fr) Procede d'obtention de myofibroblastes.

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: KIM, HYUN-SOO, SUWON-SI, KYUNGGI-DO, KR

Inventor name: KANG, YOUNG-MO, SUWON-SI, KYUNGGI-DO, KR

Inventor name: LEE, KYUNG-BOCK, SUWON-SI, KYUNGGI-DO, KR

Inventor name: PARK, SANG-KYO, PALDAL-GU, SUWON-SI, KYUNGGI-D, KR

Inventor name: LEE, SANG-KAP, DAEGU-SI, KR

8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1687413

Country of ref document: EP

Representative=s name: PATENT- UND RECHTSANWAELTE KRAUS & WEISERT, 80539